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474Objective: We sought to determine the relationship between plasma calcium and magnesium concentrations
with postoperative systemic hemodynamics and oxygen transport in neonates after the Norwood procedure.
Methods: Postoperative systemic oxygen consumption was continuously measured using respiratory mass spec-
trometry for 72 hours in 17 neonates. Arterial, superior vena caval and pulmonary venous blood gases and pres-
sures, plasma calcium, and lactate levels were measured at 2- to 4-hour intervals to calculate cardiac output, rate
pressure product, cardiac power output, systemic oxygen delivery, and oxygen extraction ratio. Plasma magne-
sium levels were measured at 2- to 8-hour intervals.
Results: Plasma calcium levels decreased in the first 8 hours from 1.08 0.13 mmol/L to 0.98 0.08 mmol/L,
followed by an increase to 1.10  0.26 mmol/L at 72 hours (P<.0001). Mg2þ change was significantly related
to time after logarithmic transformation, rapidly decreasing from 1.62  0.25 mg/L to 0.90  0.15 mg/L in the
first 40 hours and further decreasing slowly thereafter to 0.64 0.13 mg/L at 72 hours (P<.0001). Plasma mag-
nesium levels had a significant positive correlation with cardiac output (P ¼ .008) and cardiac power output
(P ¼ .01), and a negative correlation with heart rate (P ¼ .05). Plasma magnesium levels correlated positively
with systemic oxygen delivery and negatively with systemic oxygen consumption (P¼ .08 for both), resulting in
significant negative correlations with oxygen extraction ratio (P ¼ .04) and lactate levels (P ¼ .05). For a given
cardiac power output, plasma magnesium showed a significantly negative correlation with rate pressure product
(P ¼ .01). Plasma calcium levels showed the opposite trend, which was statistically insignificant except for
lactate (P ¼ .007).
Conclusions: Plasma magnesium may exert favorable effects on myocardial energetics and systemic oxygen
transport in neonates after the Norwood procedure, whereas plasma calcium may be harmful. Maintaining a rel-
atively high level of plasma magnesium and a low level of plasma calcium may improve myocardial
work efficiency and the balance of systemic and myocardial oxygen transport. (J Thorac Cardiovasc Surg
2012;144:474-9)The early postoperative course after the Norwood proce-
dure is characterized by profound systemic hemodynamic
instability and oxygen transport imbalance.1 Systemic oxy-
gen delivery (DO2) is critically low with limited reserve of
myocardial function because of the injured neonatal single
ventricle providing parallel pulmonary and systemic circu-
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The Journal of Thoracic and Cardiovascular Surg(VO2) is significantly elevated as a result of systemic in-
flammatory response to cardiopulmonary bypass (CPB),3
rewarming, and the use of inotropes.1 We have reported
the adverse effects of fever and dopamine on the VO2–
DO2 relationship as a result of predominant stimulation of
VO2 over DO2.
4 Obviously, the major goal and challenge
in the postoperative management after the Norwood proce-
dure are to optimize the balance between DO2 and VO2 at
the minimal expense of myocardial energetics.
Refined balance of plasma Ca2þandMg2þis considered to
be one of the treatment strategies in patients post-CPB. In-
tracellular hypercalcemia may accelerate adenosine tri-
phosphate breakdown and unnecessarily increases
contractility and myocardial oxygen consumption.5 The el-
evated intracellular Ca2þ after ischemia–reperfusion leads
to irreversible cellular injury.6 On the contrary, clinical
studies have suggested that hypocalcemia usually observed
post-CPB might not produce any obvious adverse effects.5,7
Of note, neonatal immature myocytes are more prone to
injury because of a reduced capacity to handle theery c August 2012
Abbreviations and Acronyms
CO ¼ cardiac output
CPB ¼ cardiopulmonary bypass
CPO ¼ cardiac power output
DO2 ¼ systemic oxygen delivery
ERO2 ¼ oxygen extraction ratio
LogMg ¼ logarithmic transformation of Mg2þ
POD ¼ postoperative day
PVR ¼ pulmonary vascular resistance
RPP ¼ rate pressure product
SVR ¼ systemic vascular resistance
VO2 ¼ systemic oxygen consumption
Dhillon et al Evolving Technology/Basic Scienceintracellular Ca2þ load.8 On the other hand, Mg2þ inhibits
Ca2þmembrane transport and thus prevents its intracellular
accumulation.9 It may also protect the neonatal myocar-
dium against the negative effects of high levels of circulat-
ing catecholamines.10
The effects of Ca2þ-induced injury and Mg2þ protection
on myocardial function have directed the use of a cardiople-
gic solution with relatively low or zero Ca2þand high Mg2þ
during CPB.11 Post-CPB management strategies remain to
be defined. Therefore, this study aimed to examine the rela-
tionship between plasma-ionized Ca2þand Mg2þconcentra-
tions and systemic hemodynamics and oxygen transport in
neonates in the early postoperative period after the Nor-
wood procedure.E
T
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SPATIENTS AND METHODS
Patients
The institutional research ethics board at the Hospital for Sick Children,
Toronto, Ontario, Canada, approved this study. The written informed con-
sent was obtained from the parents of consecutive 17 neonates (14 boys;
aged 4–16 days, median 7 days; weighing 2.8–4.2 kg, median 3.5 kg;
body surface area 0.18–0.27 m2, median 0.24 m2) with hypoplastic left
heart syndrome after the Norwood procedure between April 2004 and No-
vember 2006. Data from these patients were reported previously on many
other aspects of systemic hemodynamics and oxygen transport.1,4,12
Operative Procedure
Neonates were intubated with a cuffed endotracheal tube (Microcuff-
Heidelberg-Pediatric; Microcuff GmbH, Weinheim, Germany). General
anesthesia was maintained with inhaled isoflurane, intravenous fentanyl,
and pancuronium bromide. A standard Norwood procedure with regional
cerebral circulation was used. All neonates had a 3.5-mm right modified
Blalock–Taussig shunt with the distal anastomosis placed centrally on
the intramediastinal pulmonary artery. CPBmanagement consisted of a tar-
get flow of 125 mL/min/kg and a hematocrit value of 25% to 30% with
modified pH-stat blood gas management for uniform cooling (18C–
20C) at the esophageal site. Cardioplegic solution consisted of 2:1 blood
and crystalloid (includingMgSO4 41.5 mmol/L and 0 Ca
2þ). Selected cere-
bral perfusion was performed in all neonates at pump flows of 30 to 35 mL/
min/kg for 0 to 70 minutes (median, 44 minutes). All neonates received
aprotinin 50,000 KIU/kg and methylprednisolone 10 mg/kg before CPB.
Phenoxybenzamine 0.25 mg/kg was added to the pump prime. SeparationThe Journal of Thoracic and Cafrom CPB occurred after initiation of infusions of milrinone (0.66 mg/min/
kg) and dopamine (5 mg/min/kg). CPB duration was 66 to 172 minutes
(median, 124 minutes), aortic crossclamp duration was 39 to 126 minutes
(median, 60 minutes), and circulatory arrest was 1 to 46minutes (median, 9
minutes). Modified ultrafiltration was used in all neonates immediately af-
ter separation from CPB. A pulmonary venous line was inserted into the
orifice of the right upper pulmonary vein. The sternal incisionwas routinely
left open in all patients for delayed closure.
Postoperative Critical Care
Infants received time-cycled pressure control/pressure support ventila-
tion. Sedation and analgesia were given as a continuous intravenous infu-
sion of morphine (20–40 mg/kg/h), intermittent injections of lorazepam
(0.1mg/kg), and pancuronium (0.1mg/kg). Pancuroniumwas discontinued
when the patient achieved satisfactory hemodynamic stability. The central
esophageal temperature was monitored continuously and maintained at
36C to 37C. Vasoactive agents (milrinone, dopamine, phenoxybenz-
amine, and vasopressin) and ventilatory settings were adjusted according
to the institutional standard protocol to achieve arterial carbon dioxide ten-
sion at approximately 45 to 50 mm Hg and pH 7.3 to 7.4, mean arterial
blood pressure 40 to 45 mm Hg with systolic arterial pressure in the range
of 55 to 65 mm Hg, arterial oxygen saturation 70% to 80%, and superior
vena caval saturation of 44% to 55%. Intravenous infusions of 5% albu-
min 12.5 to 350 mL (median, 75 mL) on postoperative day (POD) 1, 15
to 190 mL (median, 60 mL) on POD 2, and 8 to 190 mL (median, 10
mL) on POD 3 were given to maintain filling pressures of 7 to 10 mm
Hg. Blood transfusions in the range of 20 to 132 mL (median, 40 mL) on
POD 1, 2 to 69 mL (median, 40 mL) on POD 2, and 30 to 102 mL (median,
30mL) on POD3were given tomaintain hemoglobin generally between 14
and 16 mg/dL. There was no standard protocol about the Ca2þ and Mg2þ
management. One patient had Mg2þ supplementation in the study period.
Ca2þwas administered in all but 1 of the patients. Depending on the clini-
cian’s judgment in response to lower Ca2þ levels, Ca2þ administration var-
ied in the range of 1.6 to 11.07mmol (median, 2.56mmol) on POD 1, 1.6 to
11.5mmol (median, 5.6mmol) on POD 2, and 1.6 to 8.8mmol (median, 5.3
mmol) on POD 3.Methods of Measurements
Systemic hemodynamic and oxygen transport variables.
VO2 was measured continuously using an AMIS2000 respiratory mass
spectrometer (Innovision A/S, Odense, Denmark). This is a highly sensi-
tive and accurate method for continuous gas analysis that allows simulta-
neous measurements of multiple gas fractions.1 Blood samples were
taken from the arterial, superior vena caval, and pulmonary venous lines
to measure blood gases, arterial Ca2þ, and lactate levels. The chest x-ray
verified correct placements of the superior vena caval and pulmonary ve-
nous sampling lines. Systemic hemodynamic and oxygen transport vari-
ables were calculated using the standard equations, including cardiac
output (CO), systemic and total pulmonary vascular resistance (PVR), in-
cluding the Blalock–Taussig shunt (systemic vascular resistance [SVR] and
total peripheral vascular resistance, respectively), systemic and pulmonary
blood flows (Qs and Qp, respectively), DO2, and oxygen extraction ratio
(ERO2).
1 All values were indexed to body surface area as calculated before
the operation.
Myocardial energetics. Rate pressure product (RPP) and cardiac
power output (CPO), the indirect indicators of myocardial oxygen con-
sumption and cardiac power, respectively, were calculated using the fol-
lowing equations:13,14
RPPðunitÞ ¼ heart rateðbeats=minÞ
3systolic arterial pressureðmm HgÞ=1000
CPOðwattsÞ ¼ COðL=minÞ3mean arterial pressureðmm HgÞ 3 0:0022rdiovascular Surgery c Volume 144, Number 2 475
FIGURE 1. Changes in plasma Ca2þand Mg2þconcentrations in 17 neonates during the first 72 hours after the Norwood procedure. Ca2þchange was sig-
nificantly related to time after quadratic transformation with a rapid decrease in the first 8 hours (ptime ¼ .0008), followed by a gradual increase thereafter
(ptime
2 ¼ 0.0006). Mg2þ change was significantly related to time after logarithmic transformation, rapidly decreasing in the first 40 hours and then slowly
decreasing thereafter (P<.0001). ICU, Intensive care unit.
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was measured with an ion selective electrode with a Radiometer 800
(Radiometer Medical ApS, Brønshøj, Denmark). Mg2þ concentration was
measured using the Beckman UniCel DxC system (Beckman Coulter
Inc, Brea, Calif) by forming chromagen with change in absorption at
520 mm proportional to Mg2þ concentration.
Study Protocol
Postoperative study parameters were recorded prospectively during the
first 72 hours after a patient’s arrival in the intensive care unit. Values of
hemodynamic and oxygen transport variables including plasma Ca2þ con-
centrations were collected at 2-hour intervals during the first 24 hours and
at 4-hour intervals in hours 25 to 72. Sampling was avoided if a change in
sedation, analgesia, ventilation, or hemodynamic management was made
within 15 minutes. Mg2þconcentration was measured at 2- to 8-hour inter-
vals in the 72-hour study period because of varied practice among individ-
ual clinicians.
Data Analysis
Post hoc analysis was performed to analyze the data collected in a pro-
spective study. Data are expressed as mean  standard deviation. Mixed
linear regression analysis for repeated measures was used to determine
the nature of any time trend of the measures over the 72-hour study period.
For some measures, various transformations of time (logarithmic and poly-
nomial) were tested regarding the best fit for the time course. Correlations
between the variables were also sought using mixed linear regression anal-
ysis for repeated measures. Logarithmic transformation of Mg2þ (LogMg)
was made in the correlation analysis. The extent of correlation was indi-
cated by parameter estimate and P value. All data analyses were performed
with SAS statistical software version 9.2 (SAS Institute, Inc, Cary, NC).
RESULTS
Patients
There was no cardiovascular collapse or death during the
study period. All neonates survived to hospital discharge
except for 1 who died of cardiac failure on POD 25. Com-
plete data sets of systemic hemodynamics and oxygen476 The Journal of Thoracic and Cardiovascular Surgtransport were obtained in all 17 neonates for 72 hours ex-
cept for 1 who was weaned from mechanical ventilation at
48 hours as reported previously.12Changes in Ca2þ, Mg2þ, and Systemic
Hemodynamics: Oxygen Transport During the Study
Period
A total of 316 Ca2þand 193Mg2þmeasurements were col-
lected. Ca2þ ranged from 0.62 to 1.59 meq/L, and Mg2þ
ranged from 0.51 to 2.09meq/L. The change in Ca2þwas sig-
nificantly related to time after quadratic transformation. It
showed a rapid decrease from 1.08  0.13 meq/L to 0.98
 0.10 meq/L in the first 8 hours (P ¼ .0008), followed by
a gradual increase thereafter to 1.10  0.21 meq/L
(P¼ .0006) at 72 hours (Figure 1). Mg2þchange was signif-
icantly related to time after logarithmic transformation, rap-
idly decreasing from1.62 0.25mg/L to 0.90 0.15mg/L in
the first 40 hours and further slowly decreasing thereafter to
0.64 0.13mg/Lat 72hours (P<.0001) (Figure 1).The char-
acteristics of the changes in systemic hemodynamic and ox-
ygen transport variables have been described (Figure 2).1,12
In addition, RPP and CPO were significantly related to
time after quadratic transformation, being initially low in
the first 18 to 20 hours, followed by a gradual increase for
the remaining 52 hours (parameter estimate ¼ 0.22 and
0.00002, respectively, P<.0001 for both).Correlations Between Ca2þ and Mg2þ and Systemic
Hemodynamics: Oxygen Transport During the Study
Period
Statistical results are shown in Table 1. LogMg showed
a negative correlation with heart rate (P ¼ .05). LogMgery c August 2012
FIGURE 2. Changes in systemic hemodynamics and oxygen transport in 17 neonates during the first 72 hours after the Norwood procedure. CO, Cardiac
output; CPO, cardiac power output; DO2, systemic oxygen delivery; ERO2, oxygen extraction ratio; RPP, rate pressure product; SAP, arterial systolic pres-
sure; SVR, systemic vascular resistance; VO2, systemic oxygen consumption.
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and CPO (P ¼ .01), and negatively with VO2 (P ¼ .08),
ERO2 (P ¼ .04), RPP (P ¼ .01), and lactate (P<.0001).
LogMg showed trends of negative correlation with systolic
mean arterial pressures, SVR, and PVR, although statisti-
cally insignificant (P ¼ .14–.22 for all). No significant cor-
relations were found with other variables. Ca2þ showed
opposite trends to the correlations of Mg2þ with hemody-
namic and oxygen transport variables but did not achieve
statistical significance except for lactate (P¼ .006). Further
analysis to include RPP showed a greater positive correla-
tion of LogMg with CPO (estimate parameter 0.18,
P ¼ .001 for LogMg). Additional correlation analyses
were performed to include inotropes and vasoactive agents
(dopamine, vasopressin, milrinone, and phenoxybenz-
amine). The correlation trends between LogMg and Ca2þ
and oxygen transport parameters remained the same. The
correlation trends between the doses of inotropes and vaso-
active agents and systemic hemodynamics and oxygen
transport were similar to those in our previous report.4,12
There was no significant correlation between the volumesThe Journal of Thoracic and Caof blood or albumin infusion with the levels of Ca2þ and
Mg2þ (P>.10 for all).
DISCUSSION
This study demonstrates that in the current undefined
clinical management of Ca2þand Mg2þlevels, Mg2þhas sig-
nificant positive correlations with CO and DO2, and nega-
tive correlations with heart rate, VO2, ERO2, and lactate
in patients after the Norwood procedure. At any given
RPP, Mg2þ has a significant and positive correlation with
CPO. Ca2þhas the opposite trends without achieving statis-
tical significance. Our data indicate that Mg2þhas beneficial
effects on myocardial energetics and systemic oxygen
transport during the early postoperative period in neonates
after the Norwood procedure, whereas Ca2þ may be
harmful.
The harmful effects of Ca2þ on cardiovascular function
after ischemia–reperfusion injury including CPB have
been well recognized. Animal experiments have shown
that increased intracellular Ca2þ after ischemia–reperfu-
sion accelerates adenosine triphosphate breakdown,rdiovascular Surgery c Volume 144, Number 2 477
TABLE 1. Statistical results of the correlations betweenMg2þandCa2þ
and systemic and myocardial oxygen transport oxygen transport
variables
Dependent variables
Ca2þ *Mg2þ
Parameter
estimate
P
value
Parameter
estimate
P
value
Heart rate (beats/min) 6.0 .47 10 .05
MAP (mm Hg) 5.0 .2 3.2 .2
SVR (Wood units/m2) 3.0 .6 3.3 .10
tPVR (Wood units/m2) 3.0 .47 3.7 .17
CO (L/min/m2) 0.35 .6 1.64 .008
CPO (watt) 0.1117 .2 0.148 .01
RPP (units) 1.8 .15 1.8 .01
VO2 (mL/min/m
2) 12.4 .4 17.9 .08
DO2 (mL/min/m
2) 12.4 .9 110 .08
ERO2 0.07 .4 0.11 .04
Lactate (mmol/L) 1.4 .007 1.1 <.0001
MAP, Mean arterial pressure; SVR, systemic vascular resistance; tPVR, total pulmo-
nary vascular resistance including the Blalock–Taussig shunt; CO, cardiac output;
CPO, cardiac power output; RPP, rate pressure product; VO2, systemic oxygen con-
sumption;DO2, systemic oxygen delivery; ERO2, oxygen extraction ratio. *Logarith-
mic transformation was made of Mg2þ to analyze the correlations.
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gen consumption,5 and causes irreversible myocardial in-
jury.15 In clinical studies, higher doses of Ca2þ
administration were associated with increased cardiac
and other organ dysfunction,6,15 longer intensive care
unit and hospital stays and mortality in patients
undergoing cardiopulmonary resuscitation,16 and CPB
in children.17
Mg2þ competes with Ca2þ for binding sites in the body,
thereby exerting beneficial effects.18 In terms of cardiovas-
cular system, Mg2þ attenuates intracellular Ca2þ overload-
ing after ischemia–reperfusion by inhibiting the Ca2þ
channels and increasing mitochondrial and sarcoplasmic re-
ticulum Ca2þ uptake.18 Therefore, use of relatively low or
zero Ca2þcardioplegic solutions and maintenance of normal
Mg2þ levels during and after heart surgery have been shown
to improve myocardial functional recovery with increased
CO in adults.19 Furthermore, Mg2þ plays an essential role
in the maintenance of resting membrane potential to de-
crease spontaneous sinus node rate, thereby allowing
more diastolic filling to increase CO.20 These reports are
in concordance with our data of the negative correlations
of Mg2þ with heart rate and positive correlation with CO.
In addition to the cardiac effect, Mg2þalso exerts a systemic
and pulmonary vasodilatory effect to reduce SVR and PVR
resulting from enhanced production and release of potent
vasodilators, such as prostacyclin from endothelium,21 in
addition to the inhibition of cellular Ca2þ entry.9,18 Lower
systemic and pulmonary arterial pressures and resistances
have been observed in patients after Mg2þ infusion during
coronary artery bypass or with congestive heart
failure.22,23 Likewise, our data showed trends of negative
correlation of Mg2þwith arterial pressure, SVR, and PVR,478 The Journal of Thoracic and Cardiovascular Surgalthough without achieving statistical significance. This
might be due to the routine use of the vasodilator
phenoxybenzamine. Nonetheless, the potential
vasodilatory effects of Mg2þ to some degree may have
contributed to the beneficial effects on CO and DO2 in
our patients.
The finding of the negative correlations of Mg2þ with
VO2 in critically ill patients is new and in part might be
due to the reduced myocardial oxygen consumption as indi-
cated by the negative correlation of Mg2þwith RPP. Mg2þ
may decrease VO2 in skeletal muscles by inhibiting cate-
cholamine release and metabolism.24 As a result of the in-
creased DO2 and decreased VO2, Mg
2þ showed
a beneficial effect on the overall balance of systemic oxygen
transport as indicated by its significant negative correlations
with ERO2 and arterial lactate levels.
We further examined the effects of Mg2þ on myocardial
energetic using CPO and RPP. CPO represents cardiac
power, whereas RPP is an indirect measure of myocardial
oxygen consumption.13,14 It has been suggested that the
ability to increase CPO on stimulation is a good
descriptor of myocardial functional reserve.25 Our data
showed a negative correlation between Mg2þ and RPP and
a positive correlation with CPO. Of note, the analysis of
the interrelationship among Mg2þ, RPP, and CPO demon-
strated that at any given RPP, Mg2þwas associated with rel-
atively greater CPO, an indication of improved efficiency of
myocardial energetics. Therefore, Mg2þmay exert benefi-
cial effects on the balance of systemic and myocardial oxy-
gen transport in neonates after the Norwood procedure, in
contrast with Ca2þ. However, none of our patients except
one was given supplemental Mg2þ, but almost all the pa-
tients received Ca2þ infusion. Our practice represents the
worldwide common practice. Our data suggest that man-
agement strategies should be refined to maintain relatively
high Mg2þ and low Ca2þ levels to improve systemic and
myocardial oxygen transport and functional outcomes.
Limitations
There are several limitations in our study. First, the hemo-
dynamic and oxygen transport data obtained from this rela-
tively small group of patients have been repeatedly used to
examine other aspects of the Norwood physiology.1,4,12
This may have introduced the potential bias in the data
across these reports. Second, the hemodynamic and
oxygen transport parameters were mostly calculated using
VO2, according to the direct Fick principle that would
induce a certain degree of mathematic coupling in their
relationships. Our present study did not examine the
relationship between VO2 and DO2. Finally, post hoc
analysis was performed in the data collected from
a prospective study. The correlation results indicate the
trends of Mg2þ and Ca2þ in our clinical practice in relation
with systemic and myocardial oxygen transport variables.ery c August 2012
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warranted and can be obtained by randomized clinical
trials with controlled Mg2þ and Ca2þ levels in patients
post-CPB.
CONCLUSIONS
Plasma Mg2þmay exert favorable effects on myocardial
energetics and systemic oxygen transport in neonates after
the Norwood procedure, whereas Ca2þ might be harmful.
Maintaining a relatively high level of Mg2þ and a low level
of Ca2þmay promote the efficiency of myocardial work and
improve the balance of systemic and myocardial oxygen
transport in neonates post-CPB. This information may
have important implications in the postoperative manage-
ment of children post-CPB.
The authors thank the surgeons for placing the superior vena
caval and pulmonary venous lines, the anesthetists for inserting
the cuffed endotracheal tubes, the nurses for drawing the blood
samples, and the respiratory therapists for measuring the blood
gases.
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